Researchers identified EXOSC10 mutations in patients with microcephaly and modeled them in mice. Loss of EXOSC10 caused ...
Anteris Technologies Global Corp. ( Anteris or the Company) (NASDAQ: AVR, ASX: AVR) a global structural heart company committed to designing, developing, and commercializing cutting-edge medical ...
– First and only disease-modifying therapy for the treatment of eligible children with MLD also receives Orphan Drug Designation and Priority Review in the Kingdom of Saudi Arabia – ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback